Novozymes Biopharma Announces Collaboration with Janssen to Evaluate Proprietary Veltis Half-Life Extension Technology

18.03.2014 - Novozymes Biopharma, part of Novozymes A/S, has announced a collaboration with Janssen Research & Development, LLC (Janssen). The agreement will enable Janssen to evaluate...